Cargando…

Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells

Breast cancer is one of the most common cancers. Even if breast cancer patients initially respond to treatment, developed resistance can lead to a poor prognosis. Cancer stem cells (CSCs) are a group of undifferentiated cells with self-renewal and multipotent differentiation characteristics. Existin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wenmin, Zhang, Lu, Liu, Suling, Chen, Ceshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562239/ https://www.ncbi.nlm.nih.gov/pubmed/36230903 http://dx.doi.org/10.3390/cells11192941

Ejemplares similares

Targeting Breast Cancer Stem Cells
por: Zhang, Lu, et al.
Publicado: (2023)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
por: Chen, Weilong, et al.
Publicado: (2018)

The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells
por: Zhao, Zhiju, et al.
Publicado: (2015)

Cancer Stem Cells and Neovascularization
por: Li, Fengkai, et al.
Publicado: (2021)

The roles and regulation of the KLF5 transcription factor in cancers
por: Luo, Yao, et al.
Publicado: (2021)

The tumor-nerve circuit in breast cancer
por: Cui, Qiuxia, et al.
Publicado: (2023)

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)

SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR
por: Zhao, Lina, et al.
Publicado: (2020)

TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway
por: Liu, Wenjing, et al.
Publicado: (2020)

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
por: Wang, Dong, et al.
Publicado: (2017)

Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
por: Dong, Haonan, et al.
Publicado: (2022)

Progress of Breast Cancer basic research in China
por: Wang, Xuerong, et al.
Publicado: (2021)

Recent advances in the role of endogenous hydrogen sulphide in cancer cells
por: Chen, Hao‐Jie, et al.
Publicado: (2023)

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)

Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond
por: Zhang, Xiaoli, et al.
Publicado: (2020)

CGRP: A New Endogenous Cell Stemness Maintenance Molecule
por: Lv, Xiaoting, et al.
Publicado: (2022)

Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair
por: Li, Jincheng, et al.
Publicado: (2023)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

The Regulation and Functions of Endogenous Retrovirus in Embryo Development and Stem Cell Differentiation
por: Xiang, Yangquan, et al.
Publicado: (2021)

Mammary stem cells, self-renewal pathways, and carcinogenesis
por: Liu, Suling, et al.
Publicado: (2005)

Endogenous estrogens—breast cancer and chemoprevention
por: Starek-Świechowicz, Beata, et al.
Publicado: (2021)

Regulation of breast cancer stem cell features
por: Czerwinska, Patrycja, et al.
Publicado: (2015)

Tongshu Capsule Down-Regulates the Expression of Estrogen Receptor α and Suppresses Human Breast Cancer Cell Proliferation
por: Du, Chengzhi, et al.
Publicado: (2014)

Human endogenous retroviruses in cancer: Expression, regulation and function
por: Gao, Yuan, et al.
Publicado: (2021)

Advance in metabolism and target therapy in breast cancer stem cells
por: Gao, Xu, et al.
Publicado: (2020)

Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1
por: Liu, Rong, et al.
Publicado: (2018)

The Role of Breast Cancer Stem Cell-Related Biomarkers as Prognostic Factors
por: Ko, Clarence Ching Huat, et al.
Publicado: (2020)

MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer
por: Niu, Tong, et al.
Publicado: (2021)

Regulating Endogenous Neural Stem Cell Activation to Promote Spinal Cord Injury Repair
por: Gilbert, Emily A. B., et al.
Publicado: (2022)

The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
por: Xiao, Yanhong, et al.
Publicado: (2017)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis
por: Liu, Bingjie, et al.
Publicado: (2018)

Stem Cell Biomarkers and Tumorigenesis in Gastric Cancer
por: Wuputra, Kenly, et al.
Publicado: (2022)

SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1
por: Qiu, Ting, et al.
Publicado: (2023)

Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications
por: Conde, Inês, et al.
Publicado: (2022)

Endogenous cardiac stem cells for the treatment of heart failure
por: Fuentes, Tania, et al.
Publicado: (2013)

Advances in exosome biomarkers for cervical cancer
por: Ran, Zihan, et al.
Publicado: (2022)

YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy
por: Yin, Qiyan, et al.
Publicado: (2022)

Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer
por: Li, Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emd8g6vsjbulh2nqj48hpu4831